In an interaction with Thiruamuthan, Assistant Editor at India Pharma Outlook, Veerendra Kumar Reddy, General Manager, Enzene Biosciences, discusses how perfusion technology is transforming biologics manufacturing by improving productivity, reducing
Concord Biotech shares surged in trade on June 10 after the company received a major regulatory boost from the United States Food and Drug Administration (USFDA). The rally came after Concord Biotech secured approval for its Abbreviated New Drug...
India is strengthening global pharmaceutical partnerships to drive innovation, expand manufacturing, and accelerate healthcare growth, with the USD 60 billion industry aiming to double in size over five years.
India’s MedTech opportunity is emerging as a major growth driver for the country’s electronics manufacturing services (EMS) industry. As competition intensifies in consumer electronics manufacturing and margins remain under pressure, leading EMS...
Alembic Pharma announced its participation in a newly incorporated Canadian company focused on developing, commercializing, distributing, and marketing pharmaceutical products in Canada. The move marks another step in the company's international...
Mumbai-based pharmaceutical company Lupin Limited has received U.S. FDA approval for Ranluspec biosimilar (ranibizumab-hkdz), a biosimilar to Lucentis used in the treatment of serious eye conditions. The approval marks an important step in Lupin...
Cancer treatment in India is facing fresh challenges as hospitals across the country report shortages of key chemotherapy drugs, raising concerns among doctors and patients. The shortage of essential medicines such as Cisplatin and Carboplat...
TheraNym Biologics, a contract manufacturing arm of Aurobindo Pharma, has inaugurated a state-of-the-art biologics manufacturing facility in Telangana with an investment of ?1,200 crore, marking a significant expansion in India’s advanced pharma...
Moderna and the Coalition for Epidemic Preparedness Innovations (CEPI) have joined forces to accelerate the development of a vaccine for the Bundibugyo strain of Ebola, marking a major step in global efforts to strengthen outbreak preparedness.
Novo Nordisk’s Wegovy has received approval in India for teenagers struggling with obesity, opening a new treatment option for young patients aged 12 years and above. The approval of Novo Nordisk’s Wegovy in India for teens battling obesity come...